loading page

Application of Computational Fluid Dynamics in Facility Fit for Manufacturing Cell Culture
  • +5
  • Zizhuo Xing,
  • Gearóid Duane,
  • Josiah O’Sullivan,
  • Cynthia Chelius,
  • Laura Smith,
  • Qin He,
  • Michael Borys,
  • Anurag Khetan
Zizhuo Xing
Bristol-Myers Squibb Company

Corresponding Author:[email protected]

Author Profile
Gearóid Duane
Bristol-Myers Squibb Ireland
Author Profile
Josiah O’Sullivan
Bristol-Myers Squibb Ireland
Author Profile
Cynthia Chelius
Bristol-Myers Squibb Company
Author Profile
Laura Smith
Bristol-Myers Squibb Company
Author Profile
Qin He
Bristol-Myers Squibb Company
Author Profile
Michael Borys
Bristol-Myers Squibb Company
Author Profile
Anurag Khetan
Bristol-Myers Squibb Company
Author Profile

Abstract

Among many operating parameters that control cell culture environment, appropriate mixing and aeration are crucial for cells to meet oxygen demand in aerobic microbial and mammalian production processes. A model-based manufacturing facility fit approach was applied to define agitation and air flow rates during cell culture process scale-up from laboratory to manufacturing, of which computational fluid dynamics (CFD) was the core modeling tool. The realizable k-ε turbulent dispersed Eulerian two-fluid model was used to simulate gas-liquid flow in the bioreactor and predict volumetric oxygen transfer coefficients ( kLa), where the simulation was performed in the basal medium and the resulting kLa was adjusted using modification factors for surfactants such as Pluronic F68 and Antifoam C. The CFD prediction of kLa resulted in adequate agreement with the empirical values in 15,000-L and 25,000-L bioreactors. The model was then applied to define a range of agitation and bottom air flow rates for meeting cellular oxygen demand and mitigating risks of cell damage and safety hazards. The recommended operating conditions led to the completion of five manufacturing runs with a 100% success rate. The model-based approach reduced the required number of at scale development batches and hence enabled seamless scale-up, shortened timelines, and cost savings in cell culture process technology transfer.